Dr. O'Regan on Breast Cancer Treatment Considerations During the COVID-19 Crisis

Ruth O’Regan, MD, provides insight on how the COVID-19 crisis is impacting the care of patients with breast cancer. She also shed light on cardiac toxicities associated with HER2-directed therapy and what those events might mean with regard to treatment decisions in light of the pandemic.

Please visit www.OncLive.com to watch the entitreity of the MJH Life Sciences News Network, which provides the latest news across a variety of healthcare specialties, and a number of interviews with experts in the medical field, many of which are focused on the ongoing COVID-19 pandemic.